List of Tables
Table 1. Diagnostic Nuclear Drug Market Trends
Table 2. Diagnostic Nuclear Drug Market Drivers & Opportunity
Table 3. Diagnostic Nuclear Drug Market Challenges
Table 4. Diagnostic Nuclear Drug Market Restraints
Table 5. Global Diagnostic Nuclear Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Diagnostic Nuclear Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Diagnostic Nuclear Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Diagnostic Nuclear Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Diagnostic Nuclear Drug
Table 10. Global Diagnostic Nuclear Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Diagnostic Nuclear Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Diagnostic Nuclear Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Diagnostic Nuclear Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Diagnostic Nuclear Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Diagnostic Nuclear Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Diagnostic Nuclear Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Diagnostic Nuclear Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Diagnostic Nuclear Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Diagnostic Nuclear Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Diagnostic Nuclear Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Diagnostic Nuclear Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Diagnostic Nuclear Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Diagnostic Nuclear Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Diagnostic Nuclear Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Diagnostic Nuclear Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Diagnostic Nuclear Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Diagnostic Nuclear Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Diagnostic Nuclear Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Cardinal Health Basic Information List
Table 32. Cardinal Health Description and Business Overview
Table 33. Cardinal Health Diagnostic Nuclear Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Cardinal Health (2019-2024)
Table 35. Cardinal Health Recent Developments
Table 36. GE Healthcare Basic Information List
Table 37. GE Healthcare Description and Business Overview
Table 38. GE Healthcare Diagnostic Nuclear Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of GE Healthcare (2019-2024)
Table 40. GE Healthcare Recent Developments
Table 41. Curium Pharma Basic Information List
Table 42. Curium Pharma Description and Business Overview
Table 43. Curium Pharma Diagnostic Nuclear Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Curium Pharma (2019-2024)
Table 45. Curium Pharma Recent Developments
Table 46. Jubilant Pharma Basic Information List
Table 47. Jubilant Pharma Description and Business Overview
Table 48. Jubilant Pharma Diagnostic Nuclear Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Jubilant Pharma (2019-2024)
Table 50. Jubilant Pharma Recent Developments
Table 51. Bracco Imaging Basic Information List
Table 52. Bracco Imaging Description and Business Overview
Table 53. Bracco Imaging Diagnostic Nuclear Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Bracco Imaging (2019-2024)
Table 55. Bracco Imaging Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Diagnostic Nuclear Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. SIEMENS Basic Information List
Table 62. SIEMENS Description and Business Overview
Table 63. SIEMENS Diagnostic Nuclear Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of SIEMENS (2019-2024)
Table 65. SIEMENS Recent Developments
Table 66. China Isotope & Radiation Basic Information List
Table 67. China Isotope & Radiation Description and Business Overview
Table 68. China Isotope & Radiation Diagnostic Nuclear Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of China Isotope & Radiation (2019-2024)
Table 70. China Isotope & Radiation Recent Developments
Table 71. Dongcheng Basic Information List
Table 72. Dongcheng Description and Business Overview
Table 73. Dongcheng Diagnostic Nuclear Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Dongcheng (2019-2024)
Table 75. Dongcheng Recent Developments
Table 76. Lantheus Basic Information List
Table 77. Lantheus Description and Business Overview
Table 78. Lantheus Diagnostic Nuclear Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Lantheus (2019-2024)
Table 80. Lantheus Recent Developments
Table 81. Eli Lilly Basic Information List
Table 82. Eli Lilly Description and Business Overview
Table 83. Eli Lilly Diagnostic Nuclear Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Eli Lilly (2019-2024)
Table 85. Eli Lilly Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Diagnostic Nuclear Drug Downstream Customers
Table 89. Diagnostic Nuclear Drug Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Diagnostic Nuclear Drug Product Picture
Figure 2. Global Diagnostic Nuclear Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Diagnostic Nuclear Drug Report Years Considered
Figure 5. Global Diagnostic Nuclear Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Nuclear Drug Revenue in 2023
Figure 7. Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tc-99m Picture
Figure 9. F-18 Picture
Figure 10. Other Picture
Figure 11. Global Diagnostic Nuclear Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Diagnostic Nuclear Drug Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Oncology
Figure 14. Product Picture of Cardiology
Figure 15. Product Picture of Other
Figure 16. Global Diagnostic Nuclear Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Diagnostic Nuclear Drug Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Diagnostic Nuclear Drug Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Diagnostic Nuclear Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Diagnostic Nuclear Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Diagnostic Nuclear Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Diagnostic Nuclear Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Diagnostic Nuclear Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Diagnostic Nuclear Drug Sales Value (%), (2019-2030)
Figure 29. United States Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. China Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. China Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. India Diagnostic Nuclear Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Diagnostic Nuclear Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. India Diagnostic Nuclear Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. Diagnostic Nuclear Drug Industrial Chain
Figure 51. Diagnostic Nuclear Drug Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
